Eurican L4 (--) - Suspension for injection
Eurican L4 (--) - Suspension for injection
Authorised
- Leptospira interrogans, serovar Canicola, strain 16070, Inactivated
- Leptospira interrogans, serovar Icterohaemorrhagiae, strain 16069, Inactivated
- Leptospira interrogans, serovar Grippotyphosa, strain Grippo Mal 1540, Inactivated
- Leptospira interrogans, serovar Bratislava, strain 16785, Inactivated
Product identification
Medicine name:
Eurican L4 (--) - Suspension for injection
Active substance:
- Leptospira interrogans, serovar Canicola, strain 16070, Inactivated
- Leptospira interrogans, serovar Icterohaemorrhagiae, strain 16069, Inactivated
- Leptospira interrogans, serovar Grippotyphosa, strain Grippo Mal 1540, Inactivated
- Leptospira interrogans, serovar Bratislava, strain 16785, Inactivated
Target species:
-
Dog
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Leptospira interrogans, serovar Canicola, strain 16070, InactivatedPresentation_strength:≥ 80% Reference:Ph.Eur. 0447 Index:0
-
Leptospira interrogans, serovar Icterohaemorrhagiae, strain 16069, InactivatedPresentation_strength:≥ 80% Reference:Ph.Eur. 0447 Index:1
-
Leptospira interrogans, serovar Grippotyphosa, strain Grippo Mal 1540, InactivatedPresentation_strength:≥ 80% Reference:Ph.Eur. 0447 Index:2
-
Leptospira interrogans, serovar Bratislava, strain 16785, InactivatedPresentation_strength:≥ 80% Reference:Ph.Eur. 0447 Index:3
Pharmaceutical form:
-
Suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07AB01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Austria
-
Belgium
-
Bulgaria
-
Croatia
-
Cyprus
-
Czechia
-
Denmark
-
Estonia
-
Finland
-
France
-
Germany
-
Greece
-
Hungary
-
Iceland
-
Ireland
-
Italy
-
Latvia
-
Liechtenstein
-
Lithuania
-
Luxembourg
-
Malta
-
Netherlands
-
Norway
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
Available in:
-
Belgium
-
Czechia
-
France
-
Luxembourg
-
Poland
-
Slovakia
-
Spain
Package description:
- Packaging:Vial (glass), Package_size:50 vials, Content:1 ml
- Packaging:Vial (glass), Package_size:10 vials, Content:1 ml
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - New active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Boehringer Ingelheim Vetmedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- Boehringer Ingelheim Animal Health France
Responsible authority:
- European Commission
Authorisation number:
This information is not available for this product.
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
English (PDF)
Download Published on: 24/10/2023
Bulgarian (PDF)
Published on: 24/10/2023
Croatian (PDF)
Published on: 24/10/2023
Czech (PDF)
Published on: 24/10/2023
Danish (PDF)
Published on: 24/10/2023
Dutch (PDF)
Published on: 24/10/2023
Estonian (PDF)
Published on: 24/10/2023
Finnish (PDF)
Published on: 24/10/2023
French (PDF)
Published on: 24/10/2023
German (PDF)
Published on: 24/10/2023
Greek (PDF)
Published on: 24/10/2023
Hungarian (PDF)
Published on: 24/10/2023
Icelandic (PDF)
Published on: 24/10/2023
Italian (PDF)
Published on: 24/10/2023
Latvian (PDF)
Published on: 24/10/2023
Lithuanian (PDF)
Published on: 24/10/2023
Maltese (PDF)
Published on: 24/10/2023
Norwegian (PDF)
Published on: 24/10/2023
Polish (PDF)
Published on: 24/10/2023
Portuguese (PDF)
Published on: 24/10/2023
Romanian (PDF)
Published on: 24/10/2023
Slovak (PDF)
Published on: 24/10/2023
Slovenian (PDF)
Published on: 24/10/2023
Spanish (PDF)
Published on: 24/10/2023
Swedish (PDF)
Published on: 24/10/2023
